0001706048-19-000005.txt : 20190710 0001706048-19-000005.hdr.sgml : 20190710 20190710122359 ACCESSION NUMBER: 0001706048-19-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190710 DATE AS OF CHANGE: 20190710 EFFECTIVENESS DATE: 20190710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rhino Labs, Inc. CENTRAL INDEX KEY: 0001706048 IRS NUMBER: 815285931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-342599 FILM NUMBER: 19948677 BUSINESS ADDRESS: STREET 1: 99 WALL ST #1504 CITY: NEW YORK STATE: NY ZIP: 10005 BUSINESS PHONE: 212-966-6554 MAIL ADDRESS: STREET 1: 99 WALL ST #1504 CITY: NEW YORK STATE: NY ZIP: 10005 D/A 1 primary_doc.xml X0708 D/A LIVE 0001706048 Rhino Labs, Inc. 99 WALL ST #1504 NEW YORK NY NEW YORK 10005 212-966-6554 DELAWARE None None Corporation true 2017 Paraag Sarva c/o Rhino Labs, Inc. 99 Wall Street, #1504 New York NY NEW YORK 10005 Executive Officer Director Promoter Benjamin Lantos c/o Rhino Labs, Inc. 99 Wall Street, #1504 New York NY NEW YORK 10005 Executive Officer Director Promoter Adam J. Plotkin c/o Rhino Labs, Inc. 99 Wall Street, #1504 New York NY NEW YORK 10005 Director Bryan Woods c/o Rhino Labs, Inc. 99 Wall Street, #1504 New York NY NEW YORK 10005 Executive Officer Ankur Jain c/o Rhino Labs, Inc. 99 Wall Street, #1504 New York NY NEW YORK 10005 Director Other Banking and Financial Services Decline to Disclose 06b true 0001706048-19-000003 2019-06-07 false true false 0 14035692 11035686 3000006 The Total Amount Sold includes $2,035,679.77 of consideration in the form of Convertible Promissory Notes (principal amounts and unpaid accrued interest thereon) false 15 0 0 0 false Rhino Labs, Inc. /s/ Benjamin Lantos Benjamin Lantos Chief Operating Officer 2019-07-10